BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 22586409)

  • 21. Interleukin-12p35 knockout promotes macrophage differentiation, aggravates vascular dysfunction, and elevates blood pressure in angiotensin II-infused mice.
    Ye J; Que B; Huang Y; Lin Y; Chen J; Liu L; Shi Y; Wang Y; Wang M; Zeng T; Wang Z; Hu H; Xu Y; Shi L; Ye D; Liu J; Jiang H; Wan J; Ji Q
    Cardiovasc Res; 2019 May; 115(6):1102-1113. PubMed ID: 30395167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction.
    Guzik TJ; Hoch NE; Brown KA; McCann LA; Rahman A; Dikalov S; Goronzy J; Weyand C; Harrison DG
    J Exp Med; 2007 Oct; 204(10):2449-60. PubMed ID: 17875676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actions of immune cells in the hypertensive kidney.
    Lu X; Crowley SD
    Curr Opin Nephrol Hypertens; 2020 Sep; 29(5):515-522. PubMed ID: 32701602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune system: role in hypertension.
    Schiffrin EL
    Can J Cardiol; 2013 May; 29(5):543-8. PubMed ID: 22902155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The central nervous system and inflammation in hypertension.
    Marvar PJ; Lob H; Vinh A; Zarreen F; Harrison DG
    Curr Opin Pharmacol; 2011 Apr; 11(2):156-61. PubMed ID: 21196131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-31 Regulates Immunosuppression in Ang II (Angiotensin II)-induced Hypertension by Targeting Ppp6C (Protein Phosphatase 6c).
    Li X; Cai W; Xi W; Sun W; Shen W; Wei T; Chen X; Sun L; Zhou H; Sun Y; Chen W; Gao P; Wang H; Li Q
    Hypertension; 2019 May; 73(5):e14-e24. PubMed ID: 30929511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interplay between Angiotensin II, TLR4 and hypertension.
    Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
    Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension.
    Vinh A; Chen W; Blinder Y; Weiss D; Taylor WR; Goronzy JJ; Weyand CM; Harrison DG; Guzik TJ
    Circulation; 2010 Dec; 122(24):2529-37. PubMed ID: 21126972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemokine receptor CX
    Ahadzadeh E; Rosendahl A; Czesla D; Steffens P; Prüßner L; Meyer-Schwesinger C; Wanner N; Paust HJ; Huber TB; Stahl RAK; Wiech T; Kurts C; Seniuk A; Ehmke H; Wenzel UO
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1526-F1535. PubMed ID: 30207169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune mechanisms in hypertension.
    De Ciuceis C; Rossini C; La Boria E; Porteri E; Petroboni B; Gavazzi A; Sarkar A; Rosei EA; Rizzoni D
    High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):227-34. PubMed ID: 24446309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune mechanisms in arterial hypertension. Recent advances.
    Wenzel UO; Ehmke H; Bode M
    Cell Tissue Res; 2021 Aug; 385(2):393-404. PubMed ID: 33394136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate and Innate-Like Immune System in Hypertension and Vascular Injury.
    Higaki A; Caillon A; Paradis P; Schiffrin EL
    Curr Hypertens Rep; 2019 Jan; 21(1):4. PubMed ID: 30659373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune cells and hypertension.
    Gan L; Ye D; Feng Y; Pan H; Lu X; Wan J; Ye J
    Immunol Res; 2024 Feb; 72(1):1-13. PubMed ID: 38044398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic Enhancement of Memory T-Cell Homing and Hypertension Sensitization.
    Xiao L; do Carmo LS; Foss JD; Chen W; Harrison DG
    Circ Res; 2020 Mar; 126(6):708-721. PubMed ID: 31928179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension.
    Mikolajczyk TP; Nosalski R; Szczepaniak P; Budzyn K; Osmenda G; Skiba D; Sagan A; Wu J; Vinh A; Marvar PJ; Guzik B; Podolec J; Drummond G; Lob HE; Harrison DG; Guzik TJ
    FASEB J; 2016 May; 30(5):1987-99. PubMed ID: 26873938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective.
    Dos Passos RR; Santos CV; Priviero F; Briones AM; Tostes RC; Webb RC; Bomfim GF
    Hypertension; 2024 Jul; 81(7):1411-1423. PubMed ID: 38686582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 22 Promotes Blood Pressure Elevation and Endothelial Dysfunction in Angiotensin II-Treated Mice.
    Ye J; Ji Q; Liu J; Liu L; Huang Y; Shi Y; Shi L; Wang M; Liu M; Feng Y; Jiang H; Xu Y; Wang Z; Song J; Lin Y; Wan J
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28974499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.
    Dixon KB; Davies SS; Kirabo A
    Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H368-H374. PubMed ID: 27986660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence.
    Caillon A; Schiffrin EL
    Curr Hypertens Rep; 2016 Mar; 18(3):21. PubMed ID: 26846785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications.
    Rai A; Narisawa M; Li P; Piao L; Li Y; Yang G; Cheng XW
    J Hypertens; 2020 Oct; 38(10):1878-1889. PubMed ID: 32890260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.